44 related articles for article (PubMed ID: 29460502)
1. Immediate biopsy of cervical cytology-negative and non-HPV-16/18 oncogenic types positive patients.
Karaca İ; Öztürk M; Comba C; Demirayak G; Alay İ; Erdoğan VŞ; Hoşgören M; Yaşar L
Diagn Cytopathol; 2018 Apr; 46(4):326-330. PubMed ID: 29460502
[TBL] [Abstract][Full Text] [Related]
2. Does the 'equal management of equal risks' model cause overtreatment in patients with positive cervical cytology results for ASCUS/non-HPV16/18 oncogenic types?
Karaca İ; Öztürk M; Comba C; Demirayak G; Erdoğan ŞV; Hoşgören M; Özdemir İA
Diagn Cytopathol; 2019 Feb; 47(2):105-109. PubMed ID: 30444320
[TBL] [Abstract][Full Text] [Related]
3. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
Castle PE; Reid J; Dockter J; Getman D
J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
[TBL] [Abstract][Full Text] [Related]
4. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
[TBL] [Abstract][Full Text] [Related]
5. The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?
Kabaca C; Giray B; Guray Uzun M; Akis S; Purut YE; Keles Peker E; Cetiner H; Bostanci Ergen E
Diagn Cytopathol; 2021 Apr; 49(4):480-486. PubMed ID: 33528903
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic human papillomavirus testing in an adolescent population with atypical squamous cells of undetermined significance.
Fletcher AH; Wilkinson EJ; Knapik JA
J Low Genit Tract Dis; 2009 Jan; 13(1):28-32. PubMed ID: 19098603
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
Dong L; Wang MZ; Zhao XL; Feng RM; Hu SY; Zhang Q; Smith JS; Qiao YL; Zhao FH
Gynecol Oncol; 2018 Jan; 148(1):103-110. PubMed ID: 29169614
[TBL] [Abstract][Full Text] [Related]
8. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
[TBL] [Abstract][Full Text] [Related]
9. Lack of HPV 16 and 18 detection in serum of colposcopy clinic patients.
Patel DA; Unger ER; Walline H; Opipari AW; Lee DR; Flowers LC; Ruffin MT
J Clin Virol; 2011 Apr; 50(4):342-4. PubMed ID: 21306941
[TBL] [Abstract][Full Text] [Related]
10. HPV status in women with high-grade dysplasia on cervical biopsy and preceding negative HPV tests.
Ge Y; Mody RR; Olsen RJ; Zhou H; Luna E; Armylagos D; Puntachart N; Hendrickson H; Schwartz MR; Mody DR
J Am Soc Cytopathol; 2019; 8(3):149-156. PubMed ID: 31097291
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the analytical and clinical performances of Abbott RealTime High Risk HPV, Hybrid Capture 2, and DNA Chip assays in gynecology patients.
Park S; Kang Y; Kim DG; Kim EC; Park SS; Seong MW
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):432-6. PubMed ID: 23791386
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
[TBL] [Abstract][Full Text] [Related]
13. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
Demarco M; Lorey TS; Fetterman B; Cheung LC; Guido RS; Wentzensen N; Kinney WK; Poitras NE; Befano B; Castle PE; Schiffman M
J Low Genit Tract Dis; 2017 Oct; 21(4):261-267. PubMed ID: 28953116
[TBL] [Abstract][Full Text] [Related]
14. Impact of Possibly Oncogenic High-Risk Human Papillomavirus (HPV) Types in Triage for ASC-US Cervical Cytology Results.
Amarosa EJ; Winer RL; Hong KJ; Mao C
J Low Genit Tract Dis; 2015 Oct; 19(4):307-10. PubMed ID: 26125096
[TBL] [Abstract][Full Text] [Related]
15. Validation of the indication for colposcopy proposed by the 2019 ASCCP risk-based management consensus guidelines: A single-center study in China.
Gui T; Chen Z; Chen F
PLoS One; 2021; 16(7):e0253493. PubMed ID: 34197472
[TBL] [Abstract][Full Text] [Related]
16. Clearance of human papillomavirus in women treated for cervical dysplasia.
Moore EE; Danielewski JA; Garland SM; Tan J; Quinn MA; Stevens MP; Tabrizi SN
Obstet Gynecol; 2011 Jan; 117(1):101-108. PubMed ID: 21173650
[TBL] [Abstract][Full Text] [Related]
17. Cytomorphometry and morphology analysis of human papillomavirus type 16 in liquid-based cervical cytology samples.
Safi Oz Z; Onak Kandemir N; Kokturk F; Ozdamar SO
Diagn Cytopathol; 2021 Jul; 49(7):885-893. PubMed ID: 33904658
[TBL] [Abstract][Full Text] [Related]
18. Leptomeningeal Carcinomatosis of a Poorly Differentiated Cervical Carcinoma Caused by Human Papillomavirus Type 18.
Zorzato P; Zambon M; Gori S; Frayle H; Gervasi MT; Del Mistro A
Viruses; 2021 Feb; 13(2):. PubMed ID: 33669206
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus testing as part of the renewed National Cervical Screening Program.
Hawkes D
Aust J Gen Pract; 2018 Jul; 47(7):412-414. PubMed ID: 30114869
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal HPV-DNA test in cervical cancer (PIONEER study): A proof of concept.
Bizzarri N; Pedone Anchora L; Cattani P; De Vincenzo R; Marchetti S; Conte C; Chiantera V; Gallotta V; Gueli Alletti S; Vizzielli G; Costantini B; Fagotti A; Fanfani F; Scambia G; Ferrandina G
Int J Cancer; 2021 Mar; 148(5):1197-1207. PubMed ID: 33152105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
